Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Monkeypox virus (MPXV) H3 protein, also known as the H3L protein, is a major envelope antigen found on the surface of the mature virion (MV) form of MPXV. It plays a critical role in viral attachment to host cells and mediates infection by binding to specific cell-surface molecules, notably heparan sulfate. The H3 protein is highly immunogenic and serves as a key target for both humoral and cellular immune responses during infection or vaccination. Recombinant forms of the MPXV-H3L protein are used as antigens in rapid diagnostic assays. Anti-H3L mAbs have potential therapeutic applications due to their neutralizing activity against live virus.
Neutralization of viral entry by monoclonal antibodies targeting H3L.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Monkeypox Virus Antigen H3 Protein (H3L).